Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04502056 · ClinicalTrials.gov registry record · NA
Covid-19 Messaging to Underserved Communities - 2nd Experiment
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 20,460
- Enrollment target
NCT04502056 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 20,460 participants.
The verdict
NCT04502056, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,460 participants
- Enrollment target
Study Summary
The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19. The sample will include African American and white adult Americans and oversample those with less than a college degree.
Interventions
- BEHAVIORAL Acknowledgement Racial Injustice AMA
- BEHAVIORAL African American Sender Acknowledgement
- BEHAVIORAL African American Sender in Informational Videos.
- BEHAVIORAL Racial Inequality Highlighted
- BEHAVIORAL AMA Acknowledgement Drug Pricing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,460 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2020-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04502056
The ClinicalTrials.gov registry entry for NCT04502056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Bureau of Economic Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acknowledgement Racial Injustice AMA is the first listed.
NCT04502056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04502056 about?
NCT04502056 is a clinical study titled "Covid-19 Messaging to Underserved Communities - 2nd Experiment". The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also te...
What is the current status of trial NCT04502056?
This trial is currently completed. It is a NA study. The enrollment target is 20,460 participants. The study started on 2020-08-07. Estimated completion is 2020-09-06.
What interventions are being tested in trial NCT04502056?
The interventions under investigation include: Acknowledgement Racial Injustice AMA (BEHAVIORAL), African American Sender Acknowledgement (BEHAVIORAL), African American Sender in Informational Videos. (BEHAVIORAL), Racial Inequality Highlighted (BEHAVIORAL), AMA Acknowledgement Drug Pricing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04502056?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.